ClinicalMetric / Countries / France / alzheimer disease
← 🇫🇷 France Trials
🇫🇷 France Country × Condition

alzheimer disease Clinical Trials in France

Active clinical trials for alzheimer disease with research sites in France. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 12 // Recruiting: 12 Phases: Phase 1, Phase 1, Phase 2 // Updated: Daily
Total Trials
12
Recruiting Now
12
Country
🇫🇷 France

Active Trials in France (12)

NCT06824142
Recruiting

Feasibility and Interest of the 3D Ephemeris for Temporal Orientation in Alzheimer's: Pilot Study

Enrollment
20 pts
Country
🇫🇷 France
Assistance Publique - Hôpitaux de P...
View Trial →
NCT02800395
Recruiting

Influence of Oxidative Stress and Nutrition Biomarkers on the Cognitive Decline Evolution in Alzheimer Disease

Enrollment
350 pts
Country
🇫🇷 France
Hospices Civils de Lyon
View Trial →
NCT06501495
Recruiting

Links Between Cognitive Deficits During Normal or Pathological Aging and Slow Waves Measured in EEG

Enrollment
90 pts
Country
🇫🇷 France
Assistance Publique - Hôpitaux de P...
View Trial →
NCT04865172
Recruiting

ECOCAPTURE for the Assessment of Apathy Under Real-life Conditions

Enrollment
120 pts
Country
🇫🇷 France
Institut National de la Santé Et de...
View Trial →
NCT06585384 Phase 1
Recruiting

Safety of a Strategy Combining Etanercept Administration With Repeated Contrast Ultrasound in Patients With Alzheimer's Disease

Enrollment
5 pts
Country
🇫🇷 France
Fondation Ophtalmologique Adolphe d...
View Trial →
NCT04946916
Recruiting

Neurofilament Light Chains and Cognitive Impairment in Chronic Psychiatric Disease

Enrollment
120 pts
Country
🇫🇷 France
Hôpital le Vinatier
View Trial →
NCT07367815 Phase 1, Phase 2
Recruiting

Allogeneic Adipose Tissue Derived-stem Cells in Alzheimer Disease

Enrollment
9 pts
Country
🇫🇷 France
University Hospital, Toulouse
View Trial →
NCT06523296
Recruiting

Presence of Anti-RACH Antibodies and Neurocognitive Disorder in Myasthenic or Alzheimers's Patients.

Enrollment
30 pts
Country
🇫🇷 France
Centre Hospitalier Universitaire de...
View Trial →
NCT05939362
Recruiting

New Imaging Biomarkers Predictive of MA Progression

Enrollment
80 pts
Country
🇫🇷 France
Poitiers University Hospital
View Trial →
NCT05288842
Recruiting

Tanycytes in Alzheimer's Disease and Frontotemporal Dementia

Enrollment
102 pts
Country
🇫🇷 France
University Hospital, Lille
View Trial →
NCT06852326
Recruiting

Designing a Tailored Primary Care Intervention to Manage the Burden of Caring for Patients Living with Alzheimer's Disease (or a Related Dementia)

Enrollment
30 pts
Country
🇫🇷 France
University Hospital, Tours
View Trial →
NCT05516667
Recruiting

Cohort of Patients with Alzheimer's Disease and Their Families.

Enrollment
1,000 pts
Country
🇫🇷 France
University Hospital, Toulouse
View Trial →

Frequently Asked Questions

How many alzheimer disease clinical trials are active in France?
There are currently 12 active clinical trials for alzheimer disease with sites in France, of which 12 are actively recruiting patients.
How can I join a alzheimer disease clinical trial in France?
To join a alzheimer disease clinical trial in France, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in France directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are alzheimer disease trials in France?
Active alzheimer disease trials in France span Phase 1, Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All France Trials → Global alzheimer disease Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology